Retroviral Vectors for HIV Immunotherapy
- 1 November 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 772 (1 DNA Vacc), 105-116
- https://doi.org/10.1111/j.1749-6632.1995.tb44736.x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Cytotoxic T-lymphocyte induction in asymptomatic HIV-1-infected patients immunized with Retrovector®-transduced autologous fibroblasts expressing HIV-1IIIB Env/Rev proteinsAIDS, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDSImmunology Today, 1994
- Recombinant Retroviral Vector Delivered Intramuscularly Localizes to the Site of Injection in MiceHuman Gene Therapy, 1994
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Induction of HIV-Specific CTL and Antibody Responses in Mice Using Retroviral Vector-Transduced CellsAIDS Research and Human Retroviruses, 1991
- CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus ReplicationScience, 1986
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986
- Activity and dexamethasone sensitivity of natural cytotoxic cell subpopulationsCellular Immunology, 1982